Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.
Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.
复制标题
DOI:
10.1007/s00380-018-1140-6
复制
发表时间:
2018-08
影响因子:
1.5
通讯作者:
Shimokawa H
中科院分区:
文献类型:
--
作者:
Kozu K;Sugimura K;Aoki T;Tatebe S;Yamamoto S;Yaoita N;Shimizu T;Nochioka K;Sato H;Konno R;Satoh K;Miyata S;Shimokawa H
It is widely known that the incidence of pulmonary arterial hypertension (PAH) is higher in female, whereas prognosis is poorer in male patients. However, sex differences in hemodynamic response to and long-term prognosis with PAH-targeted treatment in the modern era remain to be fully elucidated. We examined the long-term prognosis of 129 consecutive PAH patients (34 males and 95 females) diagnosed in our hospital from April 1999 to October 2014, and assessed hemodynamic changes in response to PAH-targeted therapy. Female patients had better 5-year survival compared with male patients (74.0 vs. 53.4%, P = 0.003); however, higher age quartiles in females were associated with poor outcome. Follow-up examination after medical treatment showed significant decreases in mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), and pulmonary arterial capacitance (PAC) in both sexes (both P < 0.05), whereas only females had a significant improvement in right ventricular end-diastolic pressure (RVEDP), right atrial pressure (RAP), cardiac index, and mixed venous oxygen saturation (SvO2) (all P < 0.05). Baseline age significantly correlated with the hemodynamic changes only in female patients; particularly, there were significant sex interactions in RVEDP and RAP (both P < 0.10). The multivariable analysis showed that SvO2 at baseline and mPAP and SvO2 at follow-up were significant prognostic factors in males, whereas the changes in mPAP, PVR, and PAC and use of endothelin-receptor antagonist in females. These results indicate that female PAH patients have better long-term prognosis than males, for which better improvements of right ventricular functions and hemodynamics may be involved.
登录
查看更多内容
影响因子:
7.5
作者:
McGoon, M. D.;Miller, D. P.
通讯作者:
Miller, D. P.
DOI:
10.1152/ajplung.00006.2015
发表时间:
2015-05-01
影响因子:
4.9
作者:
Frump, Andrea L.;Goss, Kara N.;Lahm, Tim
通讯作者:
Lahm, Tim
影响因子:
9.6
作者:
Kawut SM;Al-Naamani N;Agerstrand C;Berman Rosenzweig E;Rowan C;Barst RJ;Bergmann S;Horn EM
通讯作者:
Horn EM
DOI:
10.1183/09031936.00010409
发表时间:
2009-11
期刊:
The European respiratory journal
影响因子:
--
作者:
Austin ED;Cogan JD;West JD;Hedges LK;Hamid R;Dawson EP;Wheeler LA;Parl FF;Loyd JE;Phillips JA 3rd
通讯作者:
Phillips JA 3rd
影响因子:
37.8
作者:
Kawut SM;Lima JA;Barr RG;Chahal H;Jain A;Tandri H;Praestgaard A;Bagiella E;Kizer JR;Johnson WC;Kronmal RA;Bluemke DA
通讯作者:
Bluemke DA